How to estimate glomerular filtration rate (GFR) in pediatric cardiac patients

详细信息    查看全文

• 作者：Anne Dipchand^a ; Katherine D. Westreich^b ; Guido Filler^c ; ^d ; ^e ; ^f ; ^{guido.filler@lhsc.on.ca" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Glomerular filtration rate ; Inulin ; Creatinine ; Cystatin C ; Beta-trace protein ; Modified Schwartz formula
• 刊名：Progress in Pediatric Cardiology
• 出版年：2016
• 出版时间：June 2016
• 年：2016
• 卷：41
• 期：Complete
• 页码：3-8
• 全文大小：338 K

文摘

The management of pediatric patients with congenital heart disease and pediatric heart transplant recipients has become complex. One of the issues a pediatric cardiologist has to be mindful about is renal function, which is often impaired in these patients due to a variety of causes. There is consensus that glomerular filtration rate (GFR) is the best surrogate marker for renal function. Inulin clearance is the gold standard method for measurement of GFR, but it is invasive, cumbersome and requires bladder catheterization in smaller children. Nuclear medicine methods replaced the measurement of inulin clearance, but these methods are poorly standardized, not evaluated using appropriate two-compartmental models and have several drawbacks, including inaccuracy due to plasma protein binding or exposure to radiation. The most widely used endogenous marker of GFR, serum creatinine, is afflicted by multiple shortcomings, particularly in pediatric cardiology patients with congenital heart disease or cardiomyopathy. Creatinine is affected by dietary intake, nutritional status and muscle mass, which are often altered in these patients. Small molecular weight proteins such cystatin C may be the most promising endogenous alternatives.